Skip to content

Research and development of multi-dimensional rehabilitation precision transcranial magnetic stimulation technology targeting the left inferior parietal lobe in schizophrenia

Research and development of multi-dimensional rehabilitation precision transcranial magnetic stimulation technology targeting the left inferior parietal lobe in schizophrenia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126967
Enrollment
Unknown
Registered
2026-06-22
Start date
2025-03-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

True stimulation group:Precision transcranial active stimulation targeting the left inferior parietal lobe
Sham stimulation group:Precision transcranial sham stimulation targeting the left inferior parietal lobe

Sponsors

Suzhou Guangji Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients with schizophrenia; 2. Male or female aged 18-60 years old; 3. Able to understand and sign the written informed consent form; 4. According to the DSM-5 clinical interview, it is determined that they meet the diagnostic criteria for schizophrenia; 5. MCCB visual learning and memory score <= 22 points.

Exclusion criteria

Exclusion criteria: 1. Clearly agitated and uncooperative; 2. Other Axis I mental disorders other than schizophrenia; 3. CDSS depression scale score >= 7 points; 4. Severe severity of suicidal tendency clinical overall assessment score > 3 points (moderate); 5. Alcohol abuse in the past 1 month, or substance abuse or substance dependence in the past 6 months; 6. Suffering from severe or unstable physical diseases, including: neurological diseases (delirium, dementia, stroke, epilepsy, migraine, etc.), congestive heart failure, angina pectoris, myocardial infarction, arrhythmia, hypertension (including untreated or uncontrollable hypertension), malignant tumors, immunocompromised subjects, and subjects with blood glucose higher than 12 mmol/L; 7. rTMS treatment, such as those with metal implants in the body; 8. Pregnant or lactating women; 9. Have claustrophobia and cannot undergo magnetic resonance scanning.

Design outcomes

Primary

MeasureTime frame
Cognitive function score(MCCB);Gross functional score;

Secondary

MeasureTime frame
Positive and Negative Symptom Scales;

Countries

China

Contacts

Public ContactJunjie Wang

Suzhou Guangji Hospital

wangjunjie6723@163.com+86 512 6579 4851

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 3, 2026